Evaluation of Phase I Demonstrations of the Pharmacy Quality Alliance

Forms and Documents

Document	Type	Status	Availability
Form Form #2 Survey of Pharmacists	Form and Instruction	New	Repair queued
Form Form #1 Demonstration Staff Interviews	Form and Instruction	New	Repair queued
Attachment H -- Advance Email To Demonstration Leaders 10-19-2009.doc	Supplementary Document	Uploaded 2009-11-04	Available
Supporting Statement Part B -- Evaluation of Phase I Demonstration 10-23-2009.doc	Supporting Statement B	Uploaded 2009-11-04	Available
Attachment A -- Healthcare Research and Quality Act of 1999.pdf	Supplementary Document	Uploaded 2009-05-01	Repair queued
Attachment G -- Reminder Letter 10-19-2009.doc	Supplementary Document	Uploaded 2009-11-04	Available
Attachment F -- Cover Letter 10-19-2009.doc	Supplementary Document	Uploaded 2009-11-04	Available
Attachment E -- Advance Letter 10-19-2009.doc	Supplementary Document	Uploaded 2009-11-04	Repair queued
Supporting Statement Part A -- Evaluation of Phase I Demonstration 10-23-2009.doc	Supporting Statement A	Uploaded 2009-11-04	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
189081	Survey of Pharmacists	Form and Instruction	New
189080	Demonstration Staff Interviews	Form and Instruction	New

ICR Details

OMB Control No: 0935-0155	ICR Reference No: 200905-0935-001
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/AHRQ	Agency Tracking No:
Title: Evaluation of Phase I Demonstrations of the Pharmacy Quality Alliance
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 11/06/2009
	Date Received in OIRA: 05/07/2009
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	11/30/2010	12 Months From Approved
Responses	405	0	0
Time Burden (Hours)	226	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: AHRQ proposes to conduct an independent evaluation of five Phase I demonstrations undertaken by the Pharmacy Quality Alliance (PQA). The PQA launched the five demonstration projects to test the feasibility of implementing a pharmacy provider report card system, which will be used to provide feedback to pharmacies on their performance. The goals of the demonstrations are to obtain feedback from pharmacists on the credibility of the performance reports and their utility in performance improvement, and to identify the most efficient and useful ways to implement a performance-based quality reporting system. The evaluation will be conducted for AHRQ by its contractor, the CNA Corporation and Thomas Jefferson Medical College. The purpose of this evaluation is to identify problems associated with the implementation of a performance-based quality reporting system. The evaluation of the Phase I demonstrations will: o Test the feasibility and utility of (1) using 15 PQA claims-based measures on pharmacy performance and (2) a survey of consumers about their experience with pharmacy services, which was developed by the PQA; o Determine the resource (time and cost) requirements for collecting the data and generating the pharmacy performance reports; and o Provide a base of knowledge that enables the PQA to improve the implementation process, increase operational efficiency, reduce operational costs, and enhance the utility and validity of the performance measures. This project is being conducted pursuant to AHRQ's statutory authority to conduct and support research and evaluations on health care and on systems for the delivery of such care, including activities with respect to (1) the quality, effectiveness, efficiency, appropriateness and value of health care services and (2) quality measurement and improvement. 42 U.S.C. 299a(a)(1) and (2).

---

Authorizing Statute(s): US Code: 42 USC 299 Name of Law: Healthcare Research and Quality Act of 1999
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 6630	02/10/2009
30-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 18725	04/24/2009
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
Demonstration Staff Interviews	Form #1	Interview Guide for Demonstration Staff
Survey of Pharmacists	Form #2	Survey of Pharmacists

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	405	0	0	405	0	0
Annual Time Burden (Hours)	226	0	0	226	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This request is for a new proposed information collection.

---

Annual Cost to Federal Government: $208,874

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 05/07/2009

---